Anti-B23 antibodies identify a novel subset of SLE patients with a high frequency of anticardiolipin antibodies.
Answers are grounded in this paper and cite their sources.
Anti-B23 reactivity may mark an SLE subset with frequent anticardiolipin antibodies; hypothesis-generating and requires prospective validation before clinical adoption.
Of 164 sera with antinucleolar antibodies, 7 (4.3%) were shown by Western blotting to react with a 37-kd polypeptide in a nuclear extract of HeLa cells and with the recombinant protein expressed by a complementary DNA clone encoding the major nucleolar protein B23. Six of the 7 sera (86%) had antibodies to cardiolipin (aCL), and the sample that was negative for aCL had had lupus anticoagulant on previous testing. All 7 patients had either systemic lupus erythematosus (SLE) or a variant of SLE, suggesting that anti-B23 identifies a subset of patients with SLE associated with a high frequency of aCL.
No takes yet. Share an insight, caveat, or question.
Li et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: